CND Life Sciences' Syn-One Test® Detects Alpha-Synuclein in the Skin with High Sensitivity and Specificity in Patients with Parkinson's Disease and Related Disorders

/PRNewswire/ -- CND Life Sciences, a medical technology company pioneering the development of cutaneous neurodiagnostics, today announced topline results from...

Related Keywords

Baylor College Of Medicine ,Texas ,United States ,Arizona ,Boston ,Massachusetts ,Houston ,State Of Arizona ,American ,Christopher Gibbons ,Todd Levine ,Mary Parra ,Joseph Jankovic ,National Institute Of Neurological Disorders ,Beth Israel Deaconess Medical Center ,American Academy Of Neurology ,National Institutes Of Health ,Life Sciences ,National Institutes Of Health Under Award Numbers ,National Institute On Aging ,Movement Disorders ,Synuclein One Study ,National Institutes ,American Academy ,Annual Meeting ,Chief Medical Officer ,Syn One Test ,Distinguished Chair ,Baylor College ,Senior Scientific Advisor ,Done Tests ,American Rescue Plan Act ,National Institute ,Neurological Disorders ,Cnd Life Sciences ,